These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 5512465)

  • 1. [Rifampicin kinetics in enphropathic subjects].
    Borghetti A; Di Perna A; Novarini A; Bruschi G; Montanari A
    G Clin Med; 1970 Nov; 51(11):857-76. PubMed ID: 5512465
    [No Abstract]   [Full Text] [Related]  

  • 2. [Active treatment of renal disease in Finland].
    Stenman S; Grönhagen-Riska C
    Duodecim; 1995; 111(15):1497-504. PubMed ID: 9244706
    [No Abstract]   [Full Text] [Related]  

  • 3. How should chronic medical therapies be altered with the onset of end-stage renal disease and initiation of dialysis?
    Wyne KL; Fishbane S; Block GA; Warburton K; Berns JS; Neu AM; Warady BA
    Semin Dial; 2006; 19(1):8-24. PubMed ID: 16423174
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hepatitis in patients with kidney diseases treated with periodic dialysis].
    Pasqualicchio A; Gianfranceschi G; Bonazzi L; Verità F
    Fracastoro; 1969; 62(3):263-6. PubMed ID: 5355941
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chronic renal failure].
    Yoshitoshi Y; Maeda T; Sanjyo T; Kurokawa K
    Naika; 1965 Jul; 16(1):36-9. PubMed ID: 5884578
    [No Abstract]   [Full Text] [Related]  

  • 6. [Rifampicin therapy: data on the pharmacodynamics of the antibiotic derived from clinical practice].
    Angeli G; Pomarelli P
    Clin Ter; 1975 Jun; 73(5):461-4. PubMed ID: 1139866
    [No Abstract]   [Full Text] [Related]  

  • 7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Urinary excretion of rifampicin in kidney failure when administered alone or together with isoniazid].
    Titarenko OT; Vakhmistrova TI; Perova TL
    Antibiotiki; 1983 Sep; 28(9):698-702. PubMed ID: 6638984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Rifampicin and its clinical use].
    Fafrowicz B
    Wiad Lek; 1971 Jul; 24(3):233-8. PubMed ID: 4926926
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacokinetics and renal tolerance of rifampicin].
    Tacquet A; Devulder B; Lelievre G; Duchatelle P; Capier P; Cuvelier D; Wambergue F
    Lille Med; 1972 Nov; 17(10):1366-77. PubMed ID: 4660859
    [No Abstract]   [Full Text] [Related]  

  • 11. [Results of the first 5 years of the "chronic hemodialysis program" at Szeged].
    Gál G; Mustárdy I; Hézsai K; Kárpáti F; Petri G
    Orv Hetil; 1974 Aug; 115(33):1927-31. PubMed ID: 4846485
    [No Abstract]   [Full Text] [Related]  

  • 12. [Oral health in patients with chronic renal failure].
    Bots CP; Brand HS; Franse RL; van Nieuw AA
    Ned Tijdschr Tandheelkd; 2006 May; 113(5):182-5. PubMed ID: 16729562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Renal insufficiency in childhood. The dialytic problem].
    Mastrangelo F; Pastore G; D'Agostino F
    Minerva Nefrol; 1970; 17(4):164-73. PubMed ID: 5515288
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronic maintenance dialysis for patients with end-stage renal disease.
    Lawton RL; Siddiqui JY; Fearing MO; Kuebrich DM; Newhouse CE
    J Iowa Med Soc; 1969 Nov; 59(11):1005-14. PubMed ID: 5347416
    [No Abstract]   [Full Text] [Related]  

  • 15. [Rifampicin].
    Tousek J
    Cas Lek Cesk; 1971 Jul; 110(31):742-3. PubMed ID: 5564717
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficiency of high volume low frequency continuous ambulatory peritoneal dialysis (CAPD).
    Twardowski ZJ; Nolph KD; Prowant BF; Moore HL
    Trans Am Soc Artif Intern Organs; 1983; 29():53-7. PubMed ID: 6673281
    [No Abstract]   [Full Text] [Related]  

  • 17. Dialysis dilemmas.
    Hezel MP; Tuorto S; Adusumilli PS
    Natl Med J India; 2007; 20(3):152. PubMed ID: 17867622
    [No Abstract]   [Full Text] [Related]  

  • 18. Total body retention and intestinal absorption of orally administered calcium-47 in chronic hemodialysis patients.
    Rubinger D; Ronen M; Schachner E; Czaczkes JW
    Isr J Med Sci; 1980 Mar; 16(3):165-8. PubMed ID: 7390756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic analysis of D-xylose absorption in normal subjects and in patients with chronic renal failure.
    Craig RM; Murphy P; Gibson TP; Quintanilla A; Chao GC; Cochrane C; Patterson A; Atkinson AJ
    J Lab Clin Med; 1983 Mar; 101(3):496-506. PubMed ID: 6827177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Principles in the care of chronic kidney diseases from early diagnosis to treatment with the mechanical kidney].
    Orv Hetil; 1975 Apr; 116(14):803-6. PubMed ID: 1118151
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.